Cellenest PDRN Skin Booster in Korea: How It Differs from Rejuran — A Complete Guide

Cellenest is a Korean PDRN skin booster injected into the dermis to support tissue repair and hydration, and it sits in the same polynucleotide family as Rejuran while differing in formulation, concentration and injection protocol. Those differences matter because clinics frequently present the two as interchangeable when the underlying treatment plans are not. This guide explains what PDRN is, where Cellenest and Rejuran diverge, how sessions are typically structured, what the published evidence does and does not establish, and which questions to raise at consultation. It is written for international patients comparing skin booster options in Korea and deliberately avoids the promotional framing that makes this product category difficult to evaluate.

What PDRN and Polynucleotides Actually Are

PDRN stands for polydeoxyribonucleotide, a mixture of DNA fragments most commonly extracted and purified from salmon or trout milt. Polynucleotides (PN) describe longer chains from the same source material. Both are proposed to act on tissue repair pathways, with adenosine A2A receptor activity and modulation of local inflammatory signalling among the mechanisms most often discussed in the literature indexed on PubMed.

It is worth being precise about the limits of that description. PDRN has an established regulatory history in wound-healing and ophthalmic applications in several markets, but aesthetic dermal injection is a separate use case with a thinner evidence base. When a clinic cites decades of PDRN research, it is usually citing the wound-healing literature rather than trials of cosmetic skin quality endpoints. Both product families are regulated in Korea through the Ministry of Food and Drug Safety, and their approved indications are narrower than the marketing language around them tends to suggest.

Where Cellenest Sits in the Korean Skin Booster Market

Rejuran, launched by a Korean manufacturer, effectively created the domestic polynucleotide skin booster category and remains the reference product most international patients have heard of. Cellenest entered later as a competing PN or PDRN-based injectable, positioned by distributors on formulation and price rather than on a claim of a fundamentally different mechanism.

In practice this means Cellenest is usually encountered in one of two ways: as a clinic's default polynucleotide option when it has a supply relationship with that manufacturer, or as a lower-priced alternative offered when a patient asks about Rejuran. Neither framing tells you much clinically. The more useful questions are which specific product variant is being used, what concentration it contains, how many sessions the clinic considers a full course, and whether the quoted price is per session or per package. Product naming in this category is inconsistent across clinics and changes as manufacturers refresh their lines.

Cellenest and Rejuran Compared: Formulation and Concentration

The meaningful axes of comparison are molecular profile, concentration per syringe, syringe volume, and whether the formulation includes added hyaluronic acid or a lidocaine component for comfort. Rejuran is marketed in several variants aimed at different depths and regions, including a version formulated for the periorbital area and one combined with hyaluronic acid. Cellenest is likewise sold in more than one presentation.

Because manufacturers revise their product lines, any concentration figure quoted in a general guide risks being out of date. The practical approach is to ask the clinic to show the actual product box and the concentration printed on it at the time of treatment, rather than relying on a number found online. Two products described with the same generic term can differ several-fold in the amount of active material delivered per session, which in turn changes both the expected response and a fair price comparison.

Why Concentration Alone Does Not Predict Results

A higher concentration is not automatically better. Injection depth, the total volume placed, the spacing between sessions, and the injector's technique all influence outcome, and a more concentrated product placed too superficially is more likely to leave visible papules. Comparing two quotes purely on milligrams per syringe ignores most of what determines the result.

Injection Technique and Session Structure

Polynucleotide boosters are typically delivered as a series of microinjections into the superficial to mid dermis, either manually with a fine needle or with a mesotherapy injector gun. Some practitioners use a cannula in the periorbital region to reduce bruising risk. A commonly described course is three to four sessions spaced two to four weeks apart, with maintenance thereafter, though protocols vary between clinics and there is no single standard.

Expect transient effects immediately after treatment. Small raised papules at each injection point are usual and generally settle within a day or two; bruising, redness and tenderness are also common and typically short-lived. Results, where they occur, tend to be gradual rather than immediate, and are usually described in terms of skin texture, hydration and fine lines rather than volume or lifting. Anyone promising a dramatic change from a single session is overstating what this product category is understood to do.

Pain Management and Downtime

Topical anaesthetic applied 20 to 30 minutes beforehand is standard. Some formulations include lidocaine. Most patients return to normal activity the same day, but if you are travelling, scheduling a session at least a few days before photographs or events is sensible, since injection papules and bruising are visible.

What the Evidence Supports and What It Does Not

Published work on polynucleotide injectables for skin quality includes small clinical studies and a number of split-face trials, and the reported direction of effect is generally favourable for hydration and elasticity measures. However, sample sizes are often modest, follow-up periods short, and industry involvement common. Independent head-to-head trials comparing specific commercial products such as Cellenest and Rejuran are scarce.

That evidentiary position supports a measured conclusion: polynucleotide boosters appear to be a reasonable option for gradual skin quality improvement in appropriately selected patients, and the safety profile reported in the literature has generally been favourable, with adverse events mostly local and transient. It does not support claims that one branded product is clinically superior to another, nor claims of permanence. Patients should treat confident superiority claims from either manufacturer as marketing rather than evidence.

Candidacy, Contraindications and Realistic Expectations

These injectables are most often considered for patients with early textural change, dehydration, fine periorbital lines or post-acne dullness who want gradual improvement without surgery. They are not a substitute for treatments that address laxity or volume loss, and patients seeking lifting are usually better served by a different modality.

Caution or avoidance is generally advised during pregnancy and breastfeeding, in the presence of active local infection or inflamed acne at the treatment site, in patients with a known hypersensitivity to fish-derived material, and in those with certain autoimmune or bleeding conditions. Anticoagulant use increases bruising risk. Disclose all medications and supplements at consultation. A clinic that does not take a medical history before injecting is not following the standard of care that bodies such as the Korean Medical Association and the Korean Society of Plastic and Reconstructive Surgeons would expect.

Cost Structure and What to Confirm Before Booking

Prices for polynucleotide boosters in Seoul vary widely by district, clinic tier and whether the product is bundled into a package. Rather than anchoring to a figure, confirm five things in writing: the exact product name and variant, the number of syringes used per session, the number of sessions included in the quoted price, whether topical anaesthesia and follow-up review are included, and what happens if you need to reschedule after leaving Korea.

Ask specifically whether the price is per session or per course. A package that appears cheaper per course may include fewer syringes per session. For international patients this matters more than for local ones, because a discounted multi-session course you cannot physically return for is not a saving.

Frequently Asked Questions

Is Cellenest the same thing as Rejuran?

No. Both are polynucleotide-based injectables derived from salmon DNA fragments and are used for similar purposes, but they are different commercial products from different manufacturers, with different formulations, variants and pricing. They should not be assumed to be clinically equivalent in either direction.

How many sessions are usually needed?

Clinics commonly describe an initial course of three to four sessions spaced two to four weeks apart, followed by periodic maintenance. The number that suits a particular person depends on their skin condition and goals, and should be set at consultation rather than assumed in advance.

Can these be combined with other treatments?

They are often sequenced with laser, microneedling or botulinum toxin, but combination protocols and intervals differ between clinics. Combining treatments in a single visit can increase irritation and complicate attribution if a reaction occurs, so discuss the sequencing rationale with the treating doctor.

Is there a risk of an allergic reaction?

The material is fish-derived, so patients with known fish or seafood hypersensitivity should raise this before treatment. Reported adverse events in the literature have been predominantly local and transient, but no injectable is without risk, and any injection carries a small risk of infection, bruising, nodules or vascular complication.

Before You Book

Bring a written list of questions to your consultation: the exact product and variant, concentration, syringes per session, total sessions, inclusive price, the injector's qualifications, and the clinic's plan for managing a complication after you fly home. A clinic that answers those clearly and in writing is demonstrating the transparency you should expect. If you are weighing polynucleotide boosters against other options, compare them on what each modality is actually understood to do rather than on which product has the stronger marketing presence.

Sources consulted for this guide include the Korean Ministry of Food and Drug Safety, the Korea Health Industry Development Institute, the Korean Society of Plastic and Reconstructive Surgeons, and clinical literature indexed on PubMed. This article is general information and not medical advice; treatment decisions should be made with a licensed physician who has examined you.